SPECT/CT imaging
SPECT/CT imaging is a medical device with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
SPECT/CT Imaging of Skeletal Muscle Perfusion
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Optimising Molecular Radionuclide Therapy
Imaging of Peri-operative (periOP) Lung Injury
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Clinical Trials (7)
SPECT/CT Imaging of Skeletal Muscle Perfusion
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Optimising Molecular Radionuclide Therapy
Imaging of Peri-operative (periOP) Lung Injury
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Imaging Based Dosimetry for Individualized Internal Emitter Therapy
Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7